Table of Contents Table of Contents
Previous Page  804 / 1082 Next Page
Information
Show Menu
Previous Page 804 / 1082 Next Page
Page Background

S788

ESTRO 36 2017

_______________________________________________________________________________________________

The reproducibility of film measurements was on average

of 2%. Measurements made on the Cheese phantom

surface without mask showed an overestimation of the TPS

of 28.6% with fine grid, which is commonly used in clinic.

In presence of the mask there was an improvement of the

agreement between EBT3 measurements and TPS

estimated doses, achieving 0.7%. A considerable number

of measurements was performed on 8 patients. The mean

absolute value of the difference between measured and

TPS-calculated dose and its standard deviation was 11.6%

± 2.8% for all treatments. The average differences were

9.1% for brain and H&N (in these case measurements were

performed with mask), and -9.2% for the sarcoma. Hence,

there was an overestimation of the TPS without the

thermoplastic mask.

Conclusion

In vivo surface dose measurements with EBT3 are a useful

tool for quality assurance in tomotherapy, since the TPS

does not give accurate dose values in the first millimeters

of skin. Measurements performed both on phantom and in

vivo have shown a bolus effect due to the thermoplastic

mask, that compensates for the overestimation of the skin

dose calculated by the TPS.

EP-1490 A 3-class density method to monitor doses to

the parotid glands and spinal cord in oropharynx IMRT

N. Perichon

1

, S. Couespel

1

, C. Hervé

1

, O. Henry

1

, C.

Lafond

1,2,3

, J. Castelli

2,3,4

, A. Largent

2,3

, O. Acosta

2,3

, E.

Chajon

4

, R. De Crevoisier

2,3,4

1

Centre Eugène Marquis, Unité de Physique Médicale,

Rennes CEDEX, France

2

INSERM, U1099, RENNES, France

3

Université Rennes 1, LTSI, RENNES, France

4

Centre Eugène Marquis, Radiation Oncology

Department, Rennes CEDEX, France

Purpose or Objective

Within a perspective of dose guided/dose monitoring

adaptive radiotherapy, a crucial issue is the possibility to

calculate the dose distribution on Cone Beam CT scans

(CBCTs). The parotid glands (PGs) and the spinal cord (SC)

are among the main organs at risk (OAR) exposed to an

overdose during the course of IMRT for oropharynx

carcinoma. Dose calculation is particularly complex on

non-CT images. One clinically applicable option would be

to apply three density classes (soft tissue, air, bone) in the

CBCTs, corresponding to the density values of the planning

CT. The aim of this study was therefore to estimate the

accuracy of the dose distribution calculation within PGs

and SC by affectation of three density classes.

Material and Methods

Fifteen patients receiving IMRT for oropharyngeal cancer

had a weekly CT scan along their treatment. OAR and

target volumes were manually delineated in each CT. A 3-

class tissue (soft tissue, air and bone) segmentation was

performed in each CT scan using a manual threshold

method: over 110 UH for the bone and under -150 UH for

the air contained into the external patient contours. Soft

tissue was deduced by Boolean operation from air, bone

and external patient contour. Mean density values were

affected to the 3 classes in the weekly CTs, corresponding

to those read on the planning CT for each patient. A plan

was first generated on each planning CT scan using a 3

dose levels simultaneously integrated boost protocol

(70Gy/63Gy/56Gy in 35 fractions). The beam parameters

defined on the planning CT scan were transferred to each

weekly CT. Two dose distributions were then calculated in

these CT using an adaptive convolution algorithm: either

based on the “standard reference” CTscan, or based on

the 3 density class CT scan. The doses to the PGs (DVH and

mean dose) and the SC (D2%) calculated according to the

two CT modalities were compared (Wilcoxon test). Finally,

3D gamma index were also calculated to compare the 3D

dose distributions. We report the results for the first 5

patients.

Results

The PGs DVH and mean doses were not significantly

different according to the two CT modality based

calculation. On average, the difference for the mean dose

was 0.1 % (SD=0.7 %). The SC D2% doses were slightly

significantly higher when calculation is based on the

standard CT with a mean value of 42.94 Gy (SD=3.03 Gy)

compared to 42.52 Gy (SD=2.76 Gy) when calculated on

the 3 density classes. Figure 1 represents dose distribution

in sagittal plane calculated on 3 density class CT. Figure 2

shows the 3D gamma index map on the sagittal plane

(criteria DTA/DD 1mm/1% local dose, dose threshold 10

%): 91.7 % accepted point; gamma mean value 0.6. Most

differences between the two dose distributions seems to

appear on bone volumes.

Conclusion

This 3-class density method can be used to monitor the

fraction dose in the PGs during oropharynx cancer IMRT.

Small significant differences are observed for the highest

dose received in the spinal cord, likely due to the bone

heterogeneity.

EP-1491 Verification of FFF VMAT plans with PDIP and

GLAaS algorithms by using the new imager of

TrueBeamSTx

T. Ercan

1

, A. Levent

2

, T. Cagin

3

, S.M. Igdem

1

1

Gayrettepe Florence Nightingale Hospital, Radiation

Oncology, Gayrettepe - Istanbul, Turkey

2

Medideal Medical Projects and Solutions Inc., Medical

Physics, Istanbul, Turkey